Literature DB >> 22304574

Tag SNPs of the ancestral haplotype 57.1 do not substitute HLA-B*57:01 typing for eligibility to abacavir treatment in the Italian population.

Carla Badulli, Roberta Sestini, Ilaria Sbarsi, Marta Baroncelli, Cinzia Pizzochero, Miryam Martinetti, Berardino Porfirio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22304574     DOI： 10.2217/pgs.11.168

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  5 in total

1.  PharmGKB summary: very important pharmacogene information for human leukocyte antigen B.

Authors:  Julia M Barbarino; Deanna L Kroetz; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2015-04       Impact factor: 2.089

Review 2.  Abacavir pharmacogenetics--from initial reports to standard of care.

Authors:  Michael A Martin; Deanna L Kroetz
Journal:  Pharmacotherapy       Date:  2013-05-03       Impact factor: 4.705

3.  Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe.

Authors:  Mengfei Lu; Cathryn M Lewis; Matthew Traylor
Journal:  BMC Med Genomics       Date:  2017-06-19       Impact factor: 3.063

4.  Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.

Authors:  Cathelijne H van der Wouden; Mandy H van Rhenen; Wafa O M Jama; Magnus Ingelman-Sundberg; Volker M Lauschke; Lidija Konta; Matthias Schwab; Jesse J Swen; Henk-Jan Guchelaar
Journal:  Clin Pharmacol Ther       Date:  2019-06-12       Impact factor: 6.875

5.  A web resource for mining HLA associations with adverse drug reactions: HLA-ADR.

Authors:  Gurpreet S Ghattaoraya; Yenal Dundar; Faviel F González-Galarza; Maria Helena Thomaz Maia; Eduardo José Melo Santos; Andréa Luciana Soares da Silva; Antony McCabe; Derek Middleton; Ana Alfirevic; Rumona Dickson; Andrew R Jones
Journal:  Database (Oxford)       Date:  2016-05-17       Impact factor: 3.451
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.